Evidence map›Paper›PMID 41743428›Full record

ArticleFrontiers in allergy2025

Cross-IgE sensitization correlates with cross-anaphylaxis among peanut and multiple tree nuts in a murine model.

Anish Maskey, Michelle Carnazza, Daniel Kopulos, Madison Spears, Nan Yang, Raj K Tiwari, Jan Geliebter, Soheila Maleki, Xiu-Min Li

Abstract read
In one paragraph

Article in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anish Maskey *Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.
Michelle Carnazza *Division of R&D, General Nutraceutical Technology, LLC, Briarcliff Manor, NY, United States.
Daniel KopulosDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.
Madison SpearsDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.
Nan YangDivision of R&D, General Nutraceutical Technology, LLC, Briarcliff Manor, NY, United States.
Raj K TiwariDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.
Jan GeliebterDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.
Soheila MalekiUnited States Department of Agriculture, Agriculture Research Service, Southern Regional Research Center, New Orleans, LA, United States.
Xiu-Min LiDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, United States.

Funding

IgE Suppressing Berberine Nanomedicine for Treatment of Food AllergiesR44AI177183 · NIAID · GENERAL NUTRACEUTICAL TECHNOLOGY, LLC · PI LI, XIU-MIN, YANG, NAN · 2023 to 2024
$1.8M
IgE Suppressing Berberine Nanomedicine for Treatment of Peanut and Tree nut AllergiesR21AI176061 · NIAID · GENERAL NUTRACEUTICAL TECHNOLOGY, LLC · PI LI, XIU-MIN, YANG, NAN · 2023 to 2024
$491k
NIAID NIH HHS R21 AI176061NIAID NIH HHS R44 AI177183
6 · The paper itself

Abstract

Background: The incidence of multiple food allergies (MFA), defined as exhibiting allergic responses to two or more distinct food groups, has been increasing. Since peanut (PN)/ tree nuts (TN) MFA causes severe reactions, it is challenging to study cross-reactivity immediately using human subjects. Development of a PN/TN cross-reactivity model may provide a useful tool to understand the immunological mechanisms underlying cross-reactivity among PN/TN, and a tool to develop therapies that prevent cross-reactivity. Methods: Sensitization to the most common allergens, PN, walnut (WN), and cashew (CSH), were utilized for cross-reactive sensitization to eight other TNs (almond, pecan, pistachio, hazelnut, Brazil nut, pine nut, macadamia but, and coconut). C3H/ HeJ mice were intraperitoneally sensitized (primed) with a mixture of PN, WN, and CSH and specific (s)- IgE levels against the primed and cross-reactive TN antigens were determined. Intragastric challenges with each primed and eight unprimed allergens were performed and anaphylaxis symptoms measured. Correlation of primed IgE levels and symptoms scores with primed and unprimed allergen were conducted. Results: PN, WN, and CSH sensitization induced significant cross reactivity against other TNs, with elevated sIgE levels against both primed and unprimed allergens. Cross-reactivity was confirmed clinically, with anaphylaxis upon primed and unprimed nut challenges, exhibiting strong positive correlations among sIgE levels and anaphylaxis observed. Conclusion: Interestingly, as seen with patients, different priming nuts were capable of cross-sensitization against different groups of challenge nuts. Thus, we present a model system that can be developed to investigate the molecular basis of MFA and potential therapeutic approaches.

Indexed as

correlation analysiscross-reactive anaphylaxiscross-reactive IgEmultiple food allergyPNA/TNA

Identifiers

PMID41743428
PMCPMC12929505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.